Daily Anesthesiology Research Analysis
Three impactful anesthesiology studies stand out today: an international multicenter study defines minimal clinically important changes for acute postsurgical pain PROMs, enabling better trial design and clinical interpretation; a mechanistic Anesthesiology study shows anesthetic regimen and hyperosmolality profoundly modulate intrathecal drug distribution; and a large multicenter cohort links cumulative volatile anesthetic exposure to higher reoperation rates and sevoflurane-associated AKI afte
Summary
Three impactful anesthesiology studies stand out today: an international multicenter study defines minimal clinically important changes for acute postsurgical pain PROMs, enabling better trial design and clinical interpretation; a mechanistic Anesthesiology study shows anesthetic regimen and hyperosmolality profoundly modulate intrathecal drug distribution; and a large multicenter cohort links cumulative volatile anesthetic exposure to higher reoperation rates and sevoflurane-associated AKI after bariatric surgery.
Research Themes
- Patient-centered pain outcome thresholds for acute postsurgical care
- Anesthetic modulation of neuraxial drug distribution and glymphatic flow
- Volatile anesthetic exposure, renal risk, and surgical outcomes
Selected Articles
1. Minimal Clinically Important Changes of Patient-reported Outcome Measures for Acute Postsurgical Pain.
Across 2,661 patients from 18 centers, MCIDs for acute postsurgical pain intensity ranged from 1.2 to 1.6 points and for physical function from 1.5 to 1.6 on 0–10 scales. MCIDs did not differ between improvement and worsening, but higher baseline pain required larger changes to be meaningful (e.g., rest pain MCID 1.0 vs 2.1 for mild vs severe). These estimates enable standardized interpretation and powering of trials and QI programs.
Impact: Provides rigorously derived MCIDs for commonly used acute postsurgical PROMs using both anchor- and distribution-based methods across diverse surgeries, directly informing study design and clinical benchmarking.
Clinical Implications: Use these MCID thresholds to interpret patient-centered changes, set responder definitions, and power studies; adjust expectations and goals based on baseline pain severity. Embed MCIDs in perioperative dashboards for real-time decision-making.
Key Findings
- MCID for pain intensity was 1.2–1.6 points; for physical function 1.5–1.6 points on 0–10 scales between postoperative days 1 and 3.
- MCIDs did not differ between patients reporting minimal improvement vs minimal worsening.
- Baseline pain level influenced MCIDs (e.g., rest pain MCID 1.0 for mild vs 2.1 for severe baseline pain).
Methodological Strengths
- Large, international multicenter cohort with standardized PROMs at two early postoperative time points.
- Combined anchor-based and distribution-based approaches with sensitivity analyses.
Limitations
- Short follow-up limited to days 1 and 3 postoperatively; lacks longer-term validation.
- Heterogeneity across surgeries and centers may introduce residual confounding not fully addressed.
Future Directions: Validate MCIDs by procedure type and cultural/linguistic contexts; link MCIDs to longer-term recovery and satisfaction; integrate thresholds into electronic health records for automated responder analyses.
BACKGROUND: Patient-reported outcome measures (PROMs) are essential instruments for assessing postsurgical pain-related outcomes from the patient's perspective. The concept of minimal clinically important difference (MCID) aims to identify the smallest change in PROMs that is meaningful to patients. In this multicenter study, data were used to calculate MCIDs for several PROMs assessing pain intensity and physical function after surgery and to perform a sensitivity analysis. METHODS: Data from 2,661 patients undergoing sternotomy, total knee arthroplasty, breast surgery, or surgery related to endometriosis, recruited from 18 centers in 10 European countries, were included in the analysis. Eight PROMs were collected on days 1 and 3 after surgery, assessing pain intensity (at rest, average, worst, during movement, during physiotherapy) and physical function (in bed, during movement, during physiotherapy). MCIDs were calculated using a combination of distribution-based (30% of SD, standard error of the measurement) and anchor-based (calculating the absolute change between day 1 and day 3 for patients reporting "minimal improvement" or "minimal worsening" on 7-point global and specific impression of change scales) methods. RESULTS: The MCID estimates for pain intensity ranged from 1.2 (at rest) to 1.6 (during activity), while physical function was consistent between 1.5 (in bed) and 1.6 (during physiotherapy) on an 11-point scale. Sensitivity analyses revealed no significant difference in MCID estimates between symptom improvement and worsening for all PROMs. However, baseline pain influenced MCID estimates, with higher baseline pain leading to patients reporting higher changes as meaningful ( e.g. , for pain at rest, MCID mild pain 1.0, MCID severe pain 2.1). CONCLUSIONS: The authors found differences between MCID estimates for eight PROMs related to pain intensity and physical function. Baseline values appear to have a significant impact on what patients consider to be a minimal relevant change, which should be addressed in future studies.
2. General Anesthesia and Systemic Hyperosmolality Modulate Lumbar Intrathecal Drug Distribution in Female Rats.
In female rats, ketamine–dexmedetomidine increased spinal tracer availability and decreased intracranial exposure versus isoflurane, coinciding with a 46% expansion of the spinal subarachnoid space. Systemic hypertonic saline markedly increased intracranial availability during ketamine–dexmedetomidine and prolonged CNS retention in awake animals. These findings reveal anesthetic- and osmolality-dependent control of intrathecal drug distribution.
Impact: Demonstrates for the first time that anesthetic regimen and systemic hyperosmolality can steer intrathecal drug distribution between spinal and intracranial compartments, suggesting actionable levers to optimize neuraxial therapies.
Clinical Implications: Anesthetic choice (e.g., ketamine–dexmedetomidine vs isoflurane) and adjunctive hypertonic saline may be used to enhance spinal targeting or boost intracranial delivery for intrathecal therapeutics; clinical trials are warranted to balance efficacy and adverse effects.
Key Findings
- Ketamine–dexmedetomidine increased spinal tracer exposure (AUC0–116 ratio 1.78; P=0.0016) and reduced intracranial exposure versus isoflurane.
- Ketamine–dexmedetomidine expanded spinal subarachnoid space volume by 46% (T13–T6; P=0.0051).
- Hypertonic saline markedly increased intracranial availability during ketamine–dexmedetomidine and prolonged CNS retention in awake rats.
Methodological Strengths
- In vivo whole-body SPECT quantification combined with spinal MRI to assess both distribution and anatomical volumetrics.
- Factorial manipulation of anesthetic regimen and systemic osmolality using a high-molecular-weight tracer relevant to biologics.
Limitations
- Animal model with female rats only; human translation and sex differences remain unknown.
- Single tracer studied; therapeutic agents with differing size/charge may behave differently.
Future Directions: Pilot human studies to test HTS-assisted intrathecal delivery; evaluate different molecular sizes and disease states; define dosing windows by anesthetic regimen.
BACKGROUND: Spinal administration of drugs largely bypasses the blood-brain barrier that reduces the central nervous system (CNS) availability of most systemically administered drugs. Current methods for lumbar intrathecal drug delivery fail to deliver therapeutic concentrations to the brain, whereas intracranial drug administration carries marked risks. Cerebrospinal fluid flow along the glymphatic pathway can be pharmacologically modified with a variety of drugs including anesthetics and hypertonic saline (HTS). However, the effect of anesthetics and HTS on spinally administered drugs is highly understudied. The authors investigated how two anesthetic regimens and HTS influence the distribution of a spinally administered high-molecular-weight radiotracer. METHODS: Female rats were anesthetized with ketamine-dexmedetomidine or isoflurane. HTS (40 mOsm/kg) or isotonic saline (ITS) was administered intraperitoneally. The whole-body distribution of lumbar spinal tracer (technetium-99m radiolabeled human serum albumin nanocolloid, 66.5 kDa) was assessed with in vivo single-photon emission computed tomography. Anesthetic-induced changes in spinal subarachnoid space volume were investigated with magnetic resonance imaging. RESULTS: Compared with isoflurane, ketamine-dexmedetomidine enhanced local spinal tracer availability (area under the time-activity curve between 0 and 116 min [AUC 0-116 ] ratio, 1.78; P = 0.0016) and reduced intracranial exposure (AUC 0-116 ratio, ∞; P = 0.0260) in ITS-treated rats. Moreover, ketamine-dexmedetomidine increased the spinal subarachnoid space volume (T13-T6) by 46% ( P = 0.0051) compared with isoflurane. HTS markedly increased intracranial tracer availability compared with ITS during ketamine-dexmedetomidine anesthesia (AUC 0-116 ratio, ∞; P = 0.0047) but not isoflurane (AUC 0-116 ratio, 3.10; P = 0.1320), and prolonged CNS retention in awake rats. CONCLUSIONS: Anesthesia modulates the distribution of intrathecally administered drugs at the spinal and intracranial levels. Systemic HTS increased the intracranial availability of spinally administered drugs during ketamine-dexmedetomidine and prolonged the CNS availability of spinal drugs in the awake state. These interventions should be taken to clinical trials to improve efficacy and to reduce side effects of spinally administered drugs.
3. The association between volatile anaesthetic exposure and postoperative complications following bariatric surgery: A multicentre retrospective cohort study.
In 16,685 bariatric patients, higher cumulative age-adjusted MAC-hours were independently associated with increased postoperative complications. Reoperation risk rose with overall volatile exposure (class effect), while AKI risk increased with sevoflurane but not isoflurane exposure. Findings are hypothesis-generating and call for prospective validation.
Impact: This large, multicenter analysis links a quantitative anesthetic dosing metric (MAC-hours) to surgical complications and suggests agent-specific renal risk, informing exposure minimization strategies and agent selection in high-risk patients.
Clinical Implications: Consider strategies to reduce cumulative volatile exposure (e.g., lower MAC with adjuncts, balanced anesthesia or TIVA) and preferential agent selection in patients at renal risk; intensify renal monitoring with sevoflurane. Do not infer causality; use findings to design prospective trials.
Key Findings
- Among 16,685 patients, higher total age-adjusted MAC-hour exposure correlated with increased postoperative complications.
- Reoperation risk increased with cumulative volatile exposure (class effect).
- AKI risk was associated with sevoflurane exposure but not with isoflurane.
Methodological Strengths
- Very large multicenter cohort with standardized exposure quantification using age-adjusted MAC-hours.
- Agent-specific analyses allowing differentiation between sevoflurane and isoflurane associations.
Limitations
- Retrospective observational design with potential residual confounding and indication bias.
- Limited detail on perioperative co-interventions and postoperative care that may influence outcomes.
Future Directions: Prospective, ideally randomized or quasi-experimental studies to test exposure minimization strategies; mechanistic studies on volatile-specific nephrotoxicity; external validation across populations and procedures.
BACKGROUND: Despite the effectiveness of bariatric surgery for severe obesity, reoperation and acute kidney injury (AKI) remain significant complications. The impact of volatile anaesthetics on postoperative outcomes is unclear, and current guidelines lack evidence-based recommendations for anaesthetic selection. We investigated the association between cumulative volatile anaesthetic exposure and postoperative complications following bariatric surgery. METHODS: This multicentre retrospective study included patients undergoing laparoscopic bariatric procedures at four Israeli centres (January 2017-May 2025). Volatile anaesthetic exposure was quantified as age-adjusted minimum alveolar concentration-hours (MAC RESULTS: A total of 16,685 patients were included in the final analysis. Reoperation occurred in 122 patients (0.7 %) and AKI in 96 patients (0.6 %). Higher total MAC CONCLUSION: Cumulative volatile anaesthetic exposure was independently associated with increased postoperative complications following bariatric surgery. The association with reoperation rate appears to be a class effect, while sevoflurane, but not isoflurane, is associated with an increased risk of AKI. However, these observational associations may be influenced by residual confounding. These hypothesis-generating findings require prospective validation before clinical recommendations can be made.